Trastuzumab Deruxtecan in Advanced Breast Cancer
ConditionAdvanced Breast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorWenjin Yin
About this trial
To evaluate the efficacy and safety of trastuzumab deruxtecan in advanced breast cancer patients.
Eligibility criteria
Qualifiers
Aged ≥18 and older
Breast cancer patients meeting current guideline recommendations and planning to receive trastuzumab deruxtecan
ECOG 0-1
Disqualifiers
During pregnancy and lactation
Trial design
Treatments tested in this trial
- Trastuzumab deruxtecan
Treatment groups
118 Participants
are divided into 1 treatment groupSponsors and collaborators
Wenjin Yin
Lead sponsor
RenJi Hospital
Sponsor institution
Source ClinicalTrials.gov